Aspirin in COVID-19: Pros and cons
Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …
economic sectors even with the significant vaccination advances. In severe presentations …
[HTML][HTML] Rationales and uncertainties for aspirin use in COVID-19: a narrative review
Rationales and uncertainties for aspirin use in COVID-19: a narrative review - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Pharmacology, pharmaceutics and clinical use of aspirin: a narrative review
BJ Alegbeleye, OOP Akpoveso… - Journal of Drug …, 2020 - jddtonline.info
Background: Aspirin is one of the most frequently used and cheapest drugs in medicine.
Since its first synthesis in 1897, several medicinal roles and mechanisms of action of Aspirin …
Since its first synthesis in 1897, several medicinal roles and mechanisms of action of Aspirin …
The novel aspirin as breakthrough drug for COVID-19: a narrative review
BJ Alegbeleye, OOP Akpoveso… - … Journal of Medicine, 2020 - SciELO Espana
ALEGBELEYE, Bamidele Johnson et al. The novel aspirin as breakthrough drug for COVID-
19: a narrative review. Iberoam J Med [online]. 2020, vol. 2, n. 4, pp. 335-350. Epub 25-Dic …
19: a narrative review. Iberoam J Med [online]. 2020, vol. 2, n. 4, pp. 335-350. Epub 25-Dic …
Aspirin as an adjunctive pharmacologic therapy option for COVID-19: anti-inflammatory, antithrombotic, and antiviral effects all in one agent
US Tantry, K Schror, EP Navarese… - Journal of …, 2021 - Taylor & Francis
Introduction Pharmacologic therapy options for COVID-19 should include antiviral, anti-
inflammatory, and anticoagulant agents. With the limited effectiveness, currently available …
inflammatory, and anticoagulant agents. With the limited effectiveness, currently available …
Aspirin is related to worse clinical outcomes of COVID-19
I Kim, S Yoon, M Kim, H Lee, S Park, W Kim, S Lee - Medicina, 2021 - mdpi.com
Background and Objectives: Aspirin is used globally to reduce pain and inflammation;
however, its effect in patients with coronavirus disease (COVID-19) is not fully investigated …
however, its effect in patients with coronavirus disease (COVID-19) is not fully investigated …
Low-dose aspirin for early COVID-19: does the early bird catch the worm?
During the ongoing COVID-19 pandemic caused by SARS-CoV-2 virus, the vast majority of
patients have a mild to moderate illness that does not necessitate hospitalization and are …
patients have a mild to moderate illness that does not necessitate hospitalization and are …
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2022 - thelancet.com
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
[HTML][HTML] The effects of aspirin on the outcome of COVID-19: a systematic review and meta-analysis
Background Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a
sensible approach. However, several previous studies showed conflicting results. This meta …
sensible approach. However, several previous studies showed conflicting results. This meta …